Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Earlier this week, we gathered with over 800 rare disease advocates at the 2018 Rare Diseases & Orphan Products Breakthrough Summit hosted in Washington, D.C.
For the first time in mesothelioma, a group of researchers sequenced the genome of 74 malignant pleural mesothelioma tumors. According to the authors, the study
Last Friday, October 5, we made our second and final stop on the 2018 International Symposium on Malignant Mesothelioma tour in New York City! Executive
UPDATE: As of May 2019, the device Optune Lua, formerly known as NovoTTF-100L, was approved by the FDA under the Humanitarian Device Exemption (HDE) in
Today was a big day for immunotherapy news. Two studies we have been following closely have released their final data analyses, plus we learned that
With only one FDA-approved treatment for mesothelioma (a chemotherapy combination of Alimta (pemetrexed) and cisplatin), most advances in mesothelioma treatment are still considered experimental. As
Mesothelioma is not lung cancer, but many experts who treat mesothelioma also treat lung cancer. Therefore, this enormous conference which often boasts 7,000 to 8,000
We are deeply saddened by the passing of Dr. David Sugarbaker, a beloved mesothelioma surgeon and researcher. He leaves a huge void in the mesothelioma